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Mechanisms to coordinate programs of highly transcribed genes required for cellular homeostasis and growth are un-
clear. Upstream binding transcription factor (UBTF, also called UBF) is thought to function exclusively in RNA poly-
merase I (Pol I)-specific transcription of the ribosomal genes. Here, we report that the two isoforms of UBTF (UBTF1/2) are
also enriched at highly expressed Pol II-transcribed genes throughout the mouse genome. Further analysis of UBTF1/2
DNA binding in immortalized human epithelial cells and their isogenically matched transformed counterparts reveals an
additional repertoire of UBTF1/2-bound genes involved in the regulation of cell cycle checkpoints and DNA damage
response. As proof of a functional role for UBTF1/2 in regulating Pol II transcription, we demonstrate that UBTF1/2 is
required for recruiting Pol II to the highly transcribed histone gene clusters and for their optimal expression. Intriguingly,
lack of UBTF1/2 does not affect chromatin marks or nucleosome density at histone genes. Instead, it results in increased
accessibility of the histone promoters and transcribed regions to micrococcal nuclease, implicating UBTF1/2 in mediating
DNA accessibility. Unexpectedly, UBTF2, which does not function in Pol I transcription, is sufficient to regulate histone
gene expression in the absence of UBTF1. Moreover, depletion of UBTF1/2 and subsequent reduction in histone gene
expression is associated with DNA damage and genomic instability independent of Pol I transcription. Thus, we have
uncovered a novel role for UBTF1 and UBTF2 in maintaining genome stability through coordinating the expression of
highly transcribed Pol I (UBTF1 activity) and Pol II genes (UBTF2 activity).
[Supplemental material is available for this article.]
Transcription of ribosomal RNA (rRNA) genes (rDNA) is mediated
by RNA polymerase I (Pol I) and its associated transcription ma-
chinery to produce the 45S rRNA precursor of the 28S, 5.8S, and
18S rRNAcomponents of the ribosome (McStay andGrummt2008).
In rapidly growing mammalian cells, rRNA synthesis accounts for
35%–60% of all RNA transcription (Moss and Stefanovsky 2002;
Cavanaugh et al. 2003). Accordingly, the Pol I transcription rate is
tightly coupled to cellular growth and proliferation rates (Hannan
and Rothblum 1995; Moss and Stefanovsky 2002; McStay and
Grummt 2008; Chan et al. 2011; Hein et al. 2012; Diesch et al.
2014). We have shown that the consistent up-regulation of rRNA
synthesis in cancer cells is necessary for malignant transformation
in certain settings (Drygin et al. 2011; Bywater et al. 2012), while
small molecule inhibitors of Pol I transcription are currently in
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preclinical development and phase I trials for cancer therapy (Hein
et al. 2013; Drygin et al. 2014; Poortinga et al. 2014). Despite this,
the exact molecular mechanism by which Pol I transcription is
coordinated with Pol II transcriptional programs to ensure orderly
cellular homeostasis is not fully understood. In this report, we
propose a functional role for the Pol I-specific transcription factor
UBTF1/2 in coordinating Pol I-mediated rDNA transcription with
expression of highly active Pol II-transcribed genes.
UBTF1/2 belongs to the sequence nonspecific class of HMG
(high mobility group) proteins. It has six HMG-box homology
domains and has been proposed to interact with DNA as a dimer
and to induce six in-phase bends to generate a single 360°-loop
structure that resembles the nucleosome (Stefanovsky et al. 2001).
UBTF1/2 binds across the transcribed and control regions of the
rRNA genes (Supplemental Fig 1A; O’Sullivan et al. 2002; Sanij and
Hannan 2009), probably explaining its multiple roles in pre-
initiation complex (PIC) formation, transcription initiation, and
elongation (for review, see Moss et al. 2007; McStay and Grummt
2008; Sanij and Hannan 2009). Indeed, total ablation of Ubtf1/2
eliminates all rRNA gene transcription and leads to changes in
rDNA chromatin (Hamdane et al. 2014).
We have previously shown that UBTF1, but not the naturally
occurring splice variant UBTF2, is essential in determining and
maintaining the euchromatic state of active rDNA in mammalian
cells (Sanij et al. 2008). Further, we have reported that depletion of
Ubtf1/2 by RNA interference (RNAi) silences active rRNA genes and
is associated with histone H1-induced assembly of transcriptionally
inactive rDNA chromatin (Sanij et al. 2008). Indeed, UBTF1/2 lo-
calizes with decondensed active rDNA, while inactive rDNAs appear
as bright dense loci devoid of UBTF1/2 (Supplemental Fig. 1B) that
are enhanced in number byUbtf1/2 loss (Hamdane et al. 2014). This
is in agreement with its reported function in establishing and
maintaining the undercondensed structure of active nucleolar or-
ganizer regions (NORs), which is required for rDNA transcription
and nucleolar assembly (Mais et al. 2005; Sanij et al. 2008; Sanij and
Hannan 2009; Grob et al. 2014; Hamdane et al. 2014).
Intriguingly, UBTF2 was identified in a functional screen as an
enhancer of the beta-catenin pathway (Grueneberg et al. 2003).
Further, UBTF1/2 was noted to be putatively enriched at Pol II genes
across the human genome (Zentner et al. 2011). However, the role of
extra-nucleolar UBTF1/2 is unknown. Indeed, the prevailing con-
sensus in the transcription field is still overwhelmingly thatUBTF1/2
is exclusively a Pol I transcription factor (Grob et al. 2014). Here we
demonstrate that in addition to the Pol I loci, UBTF1/2 is enriched at
and regulates highly expressed Pol II-transcribed genes including
histone gene clusters. Further, ChIP-seq analysis of UBTF1/2 binding
in tumorigenic human epithelial cells compared to isogenically
matched primary cells reveals an additional repertoire of UBTF1/2
target genes involved in regulation of cell cycle checkpoints and
DNA damage response. Depletion of Ubtf1/2 by RNAi leads to DNA
damage and genomic instability independent of Pol I transcription.
Together, our data demonstrate a novel and unexpected role for
UBTF1 and UBTF2 in coordinating Pol I-mediated rDNA transcrip-
tionwith expressionof distinct sets of highly active Pol II-transcribed
genes that control cell cycle progression and genome integrity.
Results
UBTF1/2 binds highly active Pol II-transcribed genes
To identify a species and cell type-independent core set of UBTF1/2
target genes, we performed ChIP-seq analysis in mouse NIH3T3
cells (post-crisis, immortalized embryonic fibroblasts) and the hu-
man primary mammary epithelial cell line (HMEC) immortalized
by expressing TERT, the catalytic subunit of telomerase (Elenbaas
et al. 2001). We identified, respectively, 3705 and 10,726 genomic
regions with significant UBTF1/2 enrichment across the mouse
and human genomes, of which, respectively, 46% and 52% over-
lapped any exon/intron of known RefSeq genes (Fig. 1A,B). In both
mouse and human cells, ;40% of all UBTF1/2 binding overlapped
with first exons and introns of annotated genes. Indeed, UBTF1/2
enrichment shows preference for binding near transcription start
sites (TSSs), whereas no significant binding preference was ob-
served at the transcription termination sites (TTSs) (Fig. 1C). Gene
ontology analysis using the Genomic Regions Enrichment of An-
notation Tool (GREAT) (McLean et al. 2010) identified chromatin
assembly and nucleosome organization and assembly as the bi-
ological processes most significantly enriched with UBTF1/2-bound
genes and common between the mouse and human data sets
(Supplemental Fig. 2A,B). These categories include chromatin
remodeling factors and, significantly, a large number of histone
genes (Supplemental Tables 1, 2), implicating a role for UBTF1/2 in
their transcriptional regulation. To confirmUBTF1/2 enrichments at
these non-rDNA loci identified by ChIP-seq, we examined UBTF1/2
DNA binding manually by quantitative ChIP (qChIP) at genes
encoding histone genes, chromatin remodeling factors (Asf1a,
Smarca5, andDnmt3a), and also potential UBTF1/2 target genes that
didnot appear within gene ontological categories, e.g., deoxyuridine
triphosphatase (Dut), the oncogene Myc, and the member of the
structural maintenance of chromosome family (Smc4) (Fig. 1D). The
qChIP data showed significant enrichment in UBTF1/2 at these
genes as compared to controls, including the intergenic spacer (IGS)
of rDNA that does not bind UBTF1/2 (Fig. 1D).
We intersected the lists of annotated genes bound byUBTF1/2
within 62 kb of TSSs in the NIH3T3 and HMEC data sets and
identified 699 genes that were common between the mouse and
human analyses (Fig. 1E; Supplemental Table 14). Gene ontology
analysis of the intersected genes showed regulation of gene si-
lencing, chromatin, and nucleosome assembly categories to be the
most significantly enriched with UBTF1/2-bound genes (Supple-
mental Fig. 2C). The gene lists for these ontology terms consisted
mainly of histone genes and chromatin remodeling factors (Sup-
plemental Tables 3–5), suggesting a conserved function for UBTF1/
2 in their transcriptional regulation. Given that histone genes are
among the most highly expressed genes in the human genome
(Anamika et al. 2012), we investigated whether UBTF1/2 binding
correlates with transcriptional activity. Indeed, a correlation of
UBTF1/2 DNA binding with global gene expression in NIH3T3
cells identified genes enriched with UBTF1/2 at their TSSs to be
expressed at high levels compared to non-UBTF1/2-bound genes
and all genes in the genome (Fig. 1F).
We next examined the enrichments of a variety of post-
translational histone modifications, Pol II binding, and DNase I
hypersensitivity (HS) profiles at UBTF1/2-bound regions in NIH3T3
cells (Fig. 2A). We observed little correlation between UBTF1/2
binding and the presence of the transcriptional repressive mark
H3K9me3. However, almost 50% of the UBTF1/2 peaks overlapped
with the activating H3K4me3, H4K9ac, and H4 hyperacetylation
marks and Pol II enrichment. Further, almost 70% of UBTF1/2-
bound regions are defined as DNase I hypersensitive sites, in-
dicative of open and accessible chromatin (Fig. 2A). Thus, our data
strongly suggest specific preference for UBTF1/2 binding to open





Interestingly, UBTF1/2 ChIP-seq peaks account for only 1.7%
of all DNase I HS regions across the genome (Fig. 2A). This suggests
thatUBTF1/2 preferentially binds a specific subclass of openhighly
transcribed chromatin. In order to confirm the specificity of
UBTF1/2 binding to DNA, we performed ChIP-seq analysis of
POLR1A, the largest subunit of the RNA Pol I complex as both Pol I
and UBTF1/2 co-occupy the highly transcribed Pol I-dependent
rDNA loci (Supplemental Fig. 1A). We detected 1409 and 9296
peaks of Pol I binding across the mouse
and human genomes, some of which we
validated manually by qChIP (Supplemen-
tal Fig. 3A). However, a comparison of
UBTF1/2 and POLR1A ChIP-seq analysis in
NIH3T3 and HMEC cell lines revealed little
overlap in binding (less than 8% and 3%)
across the mouse and human genomes,
respectively (Fig. 2B). Thus the data
demonstrate that the Pol I transcription
apparatus does not simply colocalize indis-
criminately at open chromatin and that the
enrichment at classes of genes involved in
chromatin assembly and nucleosome orga-
nization is specific to UBTF1/2. Further, the
data strongly suggest that UBTF1/2 does
not recruit Pol I to Pol II genes.
Importantly, geneontologyanalysis on
the intersected UBTF1/2- and Pol II-bound
regions revealed negative regulation of
megakaryocyte differentiation, chroma-
tin assembly, and regulation of gene si-
lencing to be the biological processes
most significantly enriched (Supplemen-
tal Fig. 2D). The UBTF1/2-bound gene
lists belonging to these ontology terms
consisted mainly of chromatin remodel-
ing factors and histone genes (Supple-
mental Tables 6–9). Thus, our data,
collectively along with the known role of
UBTF1/2 in regulating rRNA gene tran-
scription, suggest that UBTF1/2 is re-
quired for transcription of distinct classes
of highly expressed genes involved in
cellular proliferative growth, including
regulators of chromatin organization.
UBTF1/2 are enriched at a novel subset
of Pol II genes in transformed human
cells
To determine whether malignant transfor-
mation is associated with altered UBTF1/2
enrichment at Pol II genes, we compared
UBTF1/2 enrichment in theHMECs (Fig. 1B)
to UBTF1/2 enrichment in the tumori-
genic HMLER cells, an isogenic HMEC-
derived cell line expressing the SV40
large-T, TERT, and an oncogenic allele of
the HRAS gene (expressing HRASV12G)
that forms tumors in nudemice (Elenbaas
et al. 2001). We identified 11,990 geno-
mic regions with UBTF1/2 enrichment.
We next intersected the UBTF1/2 ChIP-
seq data in HMECs and HMLERs to identify common and unique
regions of UBTF1/2 enrichment in HMLERs (Fig. 2C; Supplemental
Fig 2E,F) and identified 3687 UBTF1/2-bound genomic sequences
common to both the primary and the tumorigenic cell lines, with
genes encoding chromatin and nucleosome assembly being
among the most overrepresented (Supplemental Fig. 2E; Supple-
mental Table 10). Thus the regulation of histone and chromatin
remodeling genes is a fundamentally conserved function of
Figure 1. ChIP-seq analysis of UBTF1/2. Distribution of UBTF1/2 binding sites in NIH3T3 (A) and
HMEC (B) with respect to RefSeq genes as determined by Sole-Search. (C ) Average UBTF1/2 ChIP-seq
enrichment profiles at all unique TSSs and TTSs in the mouse genome 6 5 kb. (D) qChIP analysis of
UBTF1/2 binding in NIH3T3 cells to ChIP-seq genomic regions that reside within the indicated genes.
The percentage of DNA immunoprecipitated with anti-UBTF1/2 or rabbit serum (RS) antibodies was
calculated relative to the unprecipitated input control (n = 3–7; Ave 6 SEM). (*) P-value < 0.05, (**)
P-value < 0.01, compared to corresponding RS samples. Amplicons at the enhancer (ENH) and inter-
genic spacer (IGS) of rDNA were used as a positive and negative control for UBTF1/2 binding, re-
spectively. Primers to core histone genes recognize multiple genes within each class (Supplemental
Table 19). (E) Venn diagram indicating the overlap of UBTF1/2-bound genes between the NIH3T3 and
HMEC cell lines. (F) Density histograms of gene expression levels in exponentially growing NIH3T3 cells
for all genes, genes with significant UBTF1/2 ChIP-seq peaks < 2 kb from their TSS, or genes with no
UBTF1/2 binding at their TSS. Statistical significance between groups was assessed using t-tests.
Nonnucleolar functions for UBTF
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UBTF1/2 in normal and transformed cells. Gene ontology analysis
of the UBTF1/2-bound genomic regions unique to the tumorigenic
HMLERs revealed biological processes involved in regulating cell
cycle checkpoints, DNA damage checkpoints, and DNA damage
responses (Supplemental Fig. 2F). Thus, in response to oncogenic
transformation, UBTF1/2 targets an additional cohort of target
genes whose products include mediators of ATR/ATM-regulated
DNA damage response, signal transduction by TP53, and G1 to S
transition of the cell cycle (Supplemental Tables 11–13).
Identification of functional occupancy by UBTF1/2
at the histone gene clusters
To determine if UBTF1/2 binding to Pol II regulated genes has
a functional effect on gene expression, we performed expression
array analysis in control and Ubtf1/2 depleted NIH3T3 cells using
two independent short interfering RNAs (siRNAs) (Supplemental
Table 15). We intersected the ChIP-seq and microarray expression
data sets to identify genes whose expression was significantly al-
tered by Ubtf1/2 knockdown and were bound by UBTF1/2 within
500 bp of their TSSs. Gene ontology analysis, using the MetaCore
pathways software (Thomson Reuters), of the biological processes
that are enriched in the intersected list identified a significant
overrepresentation of genes belonging to chromatin/nucleosome
assembly and DNA packaging, including canonical histone genes
and histone gene variants, indicating that their transcription may
be directly regulated by UBTF1/2 (Table 1). We then chose the
histone gene clusters for further functional characterization in
examining UBTF1/2’s role in mediating Pol II transcription.
The five classes of genes encoding the canonical histone pro-
teins (H2A, H2B, H3, H4, and H1) are arranged in repetitive units in
one major and two smaller gene clusters (Marzluff et al. 2002)
somewhat reminiscent of the rDNA repeats. Histone mRNAs are
transcribed at a high rate as the cells enter S phase in parallel with
DNA replication (Marzluff et al. 2008). In addition, there are rep-
Figure 2. UBTF1/2 binding correlates with markers of open active chromatin. (A) Venn diagram indicating overlap of UBTF1/2 binding sites with various
chromatin marks, DNase I HS, and Pol II binding in NIH3T3. (B) Venn diagram indicating the overlap of UBTF1/2 and Pol I (POLR1A) binding sites in
NIH3T3 and HMEC. (C ) Venn diagram indicating the overlap of UBTF1/2 binding sites between HMEC and HMLER cell lines.
Table 1: MetaCore ontology analysis of UBTF1/2-bound genes within 500 bp of their TSSs that are differentially expressed following Ubtf1/2
knockdown in NIH3T3 cells
Enrichment analysis report
CommonEnrichment by GO processes
# Processes Total P-value In data
1 Chromatin assembly 130 3.185 3 1013 14
2 Enzyme-linked receptor protein signaling pathway 820 3.217 3 1013 29
3 DNA packaging 176 1.397 3 1012 15
4 Chromatin assembly or disassembly 146 1.599 3 1012 14
5 Protein-DNA complex assembly 146 1.599 3 1012 14
6 Nucleosome assembly 124 3.266 3 1012 13
7 Protein-DNA complex subunit organization 154 3.332 3 1012 14
8 System development 3997 4.532 3 1012 64
9 Multicellular organismal development 4704 7.630 3 1012 70
10 DNA conformation changes 205 1.270 3 1011 15
Only the most significantly enriched gene ontologies are listed. P-value denotes the significance of the number of genes from the intersected list (In data)




lication-independent variant histone genes that are not located
within the histone gene clusters and are constitutively transcribed
throughout the cell cycle. These genes encode histone variants
such as H1.0, H2A.Z, H2A.X, H3.3A, and H3.3B, which are known
to have distinct functions (Marzluff et al. 2008).
We detected robust peaks of UBTF1/2 enrichment at 33/45
canonical histone genes and 4/6 histone H1 genes within histone
cluster 1, 4/10 geneswithin histone cluster 2 (Fig. 3A,B), and also at
the single histone H4 gene located on chromosome 12 in NIH3T3,
but none at the small histone cluster 3. In addition, UBTF1/2
Figure 3. UBTF1/2 binds histone genes. (A–C) IGV (Integrated Genome Viewer) screenshots of mapped reads from UBTF1/2 ChIP and input gDNA at
mouse histone gene cluster 1 (A), cluster 2 (B), and histone variant genes H2afx and H3f3a (C ) in NIH3T3 cells. (D) qChIP analysis of UBTF1/2 binding to
canonical and variant histone genes in NIH3T3 cells. qChIPs were performed as described in Figure 1D (n = 4; Ave6 SEM). (*) P-value < 0.05, (**) P-value <
0.01, compared to corresponding RS samples. Amplicons at Hist1h1a and major satellite repeats were used as a negative control for UBTF1/2 binding.
Nonnucleolar functions for UBTF
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binding was detected at six histone gene variants, which are dis-
persed across the genome, including H2afy, H2afx, H2afz, H3f3a,
H3f3b, and H1f0 (Fig. 3C). A similar enrichment of UBTF1/2 was
observed at histone gene clusters and histone variants in HMEC
(Supplemental Fig. 3B,C; Supplemental Tables 16, 17).
Using qChIP, we confirmed significant enrichment of UBTF1/2
binding at the canonical and histone variant genes compared to
two regions that ChIP-seq data indicate are not bound by UBTF1/2
(the major satellite repeats and an amplicon specific to Hist1h1a)
(Fig 3D). These data suggest that histone genes are likely bona fide
targets of UBTF1/2.
UBTF1/2 mediates histone gene expression
As Ubtf1/2 depleted NIH3T3 cells display a delay in G1-S pro-
gression (Supplemental Fig. 3D), we examined the effect of Ubtf1/2
depletion on histone mRNA levels in sorted G1 and S populations
from sirEgfp control andUbtf1/2 knockdown samples to control for
any cell cycle bias. Histone H4 and H2afx mRNA levels were sig-
nificantly reduced followingUbtf1/2 knockdown in theG0/G1 and
in the S phase samples (Fig. 4A), suggesting that the decrease in
histone mRNA expression is a direct consequence of Ubtf1/2 knock-
down rather than accumulation of cells in G1. Indeed, in the G0/G1
populations, mRNA levels of all canonical and histone variant
mRNAs were significantly decreased following Ubtf1/2 depletion
(Fig. 4B). Thus, UBTF1/2 plays a permissive role inmediatingmRNA
expression of canonical and variant histone genes rather than
functioning in the activation of canonical histone gene expression
in S phase. Furthermore, consistent with UBTF1/2 regulatingmRNA
expression of histone genes, transient Ubtf1/2 knockdown signifi-
cantly reduced the abundance of histone proteins as represented by
H2A and H1 (Supplemental Fig. 4A,B).
UBTF1/2 mediates Pol II recruitment and transcription
of histone genes independent of chromatin modifications
or nucleosome loading
To examine the mechanism underlying UBTF1/2-mediated regu-
lation of histone gene expression, we performed sequential ChIP
assays (ChIP-reChIP) experiments to investigate the overlap be-
tween UBTF1/2 and Pol II or Pol I at histone genes. The data
showed that UBTF1/2 and Pol II simultaneously occupy histone
genes (Supplemental Fig. 4C). Consistent with the lack of overlap
observed inUBTF1/2 and Pol I binding across the genome (Fig. 2B),
we observed no enrichment in Pol I occupancy at histone genes
(Fig. 4C; Supplemental Fig. 4C). This eliminates the possibility of
UBTF1/2 recruiting Pol I to histone gene loci.
To confirm that UBTF1/2 directly regulates transcription of
histone genes via Pol II, we examined Pol II recruitment to histone
genes in response to modulation of UBTF1/2 levels. To a large ex-
tent, the phosphorylation status of the C-terminal domain (CTD)
of the largest subunit of Pol II defines the stage of transcription
(Phatnani and Greenleaf 2006). Pol II is recruited into the PICwith
a hypophosphorylated CTD; the CTD is phosphorylated on Serine
5 (Ser5) during initiation and promoter clearance and then on
Serine 2 (Ser2) during elongation (Fuda et al. 2009). We observed
significant reductions in total Pol II and Pol II (Ser5) loading at
histone H2a, H4, and H1 genes in Ubtf1/2 depleted cells (Fig. 4C),
suggesting that UBTF1/2 is required for recruitment and initiation
of Pol II transcription at histone genes. Interestingly, we also ob-
served proportionally greater reduced occupancy of elongating Pol
II (Ser2) at histone genes compared to the observed reduction in
Pol II loading/initiation following Ubtf1/2 knockdown. This sug-
gests a role for UBTF1/2 in mediating Pol II elongation rates, con-
sistent with its ability to mediate Pol I elongation (Stefanovsky
et al. 2006).
Ubtf1/2 knockdown did not correlate with any significant
changes in chromatin modifications at histone H2a and H1 genes
(Supplemental Fig. 4D), indicating that UBTF1/2’s role in regulat-
ing histone gene expression is downstream or independent of the
establishment of the euchromatic environmentwithin the histone
gene clusters. Furthermore, we did not observe significant changes
in the enrichment of histones H3, H4, or linker histoneH1 loading
at histone H2a and H1 genes following Ubtf1/2 knockdown (Sup-
plemental Fig. 4D). Thus, UBTF1/2 does not alter nucleosome
loading at histone genes. To further examine the effect of UBTF1/2
binding on chromatin remodeling events at histone genes, we
designed primers tiling the 340-bp region that spans the promoter,
the TSS, and the transcribed region of Hist1h2ad and performed
qChIP (Fig. 4D). UBTF1/2 binding atHist1h2adwas;10- to 15-fold
higher at amplicons within the transcribed region compared to the
promoter (Fig. 4E). We then examined nucleosome positioning at
Hist1h2ad by chromatin accessibility assay (CHART-PCR) (Rao
et al. 2001). Micrococcal nuclease (MNase) accessibility measure-
ments of control samples revealed the region spanning 194 to
+15 bp of Hist1h2ad (amplicons P-1, P-2, and A) is highly sensitive
to MNase digestion compared to the transcribed region (+32 to
+144 bp, amplicons B and C) (Fig. 4F), suggesting that it is depleted
of a nucleosome as expected for a highly constitutively transcribed
gene. Despite the fact that histone genes are present within an
open chromatin context (Hovhannisyan et al. 2003; Medina et al.
2012), Ubtf1/2 knockdown led to a significant decrease in pro-
tection against MNase digestion at the promoter and also at the
transcribed region (Fig. 4F). This suggests that UBTF1/2 interacts
directly with DNA as opposed to nucleosomes and its binding
modulates DNA accessibility to promote Pol II binding independent
of nucleosome occupancy. The data further suggest that UBTF1/2-
wrapped chromatin (Stefanovsky et al. 2001) is a preferred template
for Pol II rather than histone-wrapped chromatin.
UBTF2 is required for optimal histone gene expression
UBTF2 is inactive in regulating rDNA transcription compared with
UBTF1 (Grummt 1999; Hannan et al. 1999; Stefanovsky and Moss
2008) and does not function in remodeling chromatin at the rDNA
repeats in the absence of UBTF1 (Sanij et al. 2008). To address the
relative contribution of UBTF1 and UBTF2 isoforms to Pol II his-
tone gene expression, we performed replacement experiments
with rat FLAG-Ubtf1 and FLAG-Ubtf2 cDNAs, which contain
nucleic acid sequence differences in the region targeted by the
murine-specific sirUbtf1/2 (Supplemental Fig. 5A; Sanij et al. 2008),
and performed qChIP assays using anti-FLAG antibodies. We
found that both FLAG-rUBTF1 and FLAG-rUBTF2 can interact with
histone genes independently of endogenous UBTF1 and UBTF2
(Supplemental Fig. 5B). Next, we performed RNAi knockdown
targeting Ubtf1 and Ubtf2 mRNAs or only Ubtf1 mRNA (we are
unable to selectively target Ubtf2 by RNAi) (Fig. 5A). While total
UBTF1/2 enrichment was significantly reduced at histone genes in
Ubtf1/2 depleted cells, Ubtf1 knockdown cells exhibited similar
enrichment of total UBTF1/2 loading to control cells, indicating
that UBTF2 is able to fully occupy histone genes independently of
UBTF1 (Fig. 5B). Moreover, while Ubtf1/2 knockdown significantly
reduced histone H2a, H1, and H4 mRNA levels, Ubtf1 knockdown




sufficient to regulate histone gene expression in the absence of
UBTF1 (Fig. 5B). In direct contrast, at the rDNA loci both Ubtf1/2
and Ubtf1 knockdown led to a similar 50% reduction in 45S rRNA
levels (Fig. 5A). Thus, although UBTF2 is known to be inactive in
Pol I transcription (Grummt 1999;Hannan et al. 1999; Stefanovsky
and Moss 2008) and chromatin remodeling at rDNA (Sanij et al.
Figure 4. UBTF1/2 regulates histone gene expression by mediating Pol II recruitment. (A) NIH3T3 cells were transfected with sirEgfp or sirUbtf1/2#1 for
48 h, then collected and incubated with Vybrant DyeCycle Violet stain (Life Technologies). Cells were then analyzed using BD FACSAria, and G1 and S
phase populations were sorted based on DNA content. Total RNA was extracted and Ubtf1/2, Histone H4, and H2afx mRNA levels were determined by
reverse transcription qPCR. mRNA levels were normalized to beta-2-microglobulin (B2m) mRNA and expressed as fold change relative to sirEgfp/G0/G1
(n = 4). (B) Total RNA samples from G1 population of NIH3T3 cells transfected with sirEgfp or sirUbtf1/2#1 as in A were analyzed by reverse transcription
qPCR for mRNA expression of various canonical and variant histone genes as indicated (n = 4). (C ) UBTF1/2 mediates Pol II recruitment, initiation, and
elongation at histone genes. qChIP analysis of the histone H2a, H4, and H1 genes in sirEgfp- or sirUbtf1/2#1-transfected NIH3T3 cells using antibodies
against Pol I (n = 2), total Pol II (n = 7), phospho Pol II-Ser5 (n = 4), or phospho Pol II-Ser2 (n = 4). The percentage of DNA immunoprecipitated with the
indicated antibodies or RS was calculated relative to the unprecipitated input control. Percentage of DNA of RS controls was subtracted. (D) Ubtf1/2
knockdown leads to increased DNA accessibility at Hist1h2ad. Screenshots of IGV with the mapped reads from UBTF1/2 ChIP and input gDNA in NIH3T3
to Hist1h2ad. Primers used for qPCR are indicated (Supplemental Table 21). (E) qChIP analysis of UBTF1/2 binding at Hist1h2ad in sirEgfp or sirUbtf1/2#1
transfected NIH3T3 cells. qChIPs were performed as described in Figure 4C (n = 3). (F) Chromatin remodeling of the Hist1h2ad by UBTF1/2. Nuclei from
NIH3T3 cells transfected with either sirEgfp or sirUbtf1/2#1 for 48 h were incubated with or without MNase. Extracted gDNAwas subjected to qPCR using
primers outlined in D. MNase accessibility was expressed as a percentage of undigested gDNA samples (n = 3). In all graphs (A–F), error bars represent
Ave 6 SEM, (*) P-value < 0.05, (**) P-value < 0.01, (***) P-value < 0.001, compared to corresponding sirEgfp samples.
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2008), these data demonstrate that UBTF2 functions to enhance
Pol II gene expression.
Ubtf1/2 knockdown leads to DNA damage and genomic
instability
In eukaryotes, DNA damage and repair occurs in the context of
chromatin and thus histone availability affects genome integrity
and stability (Ye et al. 2003; Gunjan et al. 2005). Thus, the loss of
histone gene expression following Ubtf1/2 depletion might be
associated with DNA damage and/or genome instability. To in-
vestigate this possibility, we used the comet assay to detect DNA
damage at the single-cell level and found that Ubtf1/2 knock-
down cells exhibited significantly longer comet tails than those
of control cells, indicating that they accumulated DNA damage
(Fig. 6A).
The appearance of micronuclei is another characteristic
marker of damaged chromosomes. Micronuclei are small nuclei
separated from the main nucleus, containing chromosomes or
chromosome fragments derived from mitotic spindle dysfunction
(Fenech 2006). We performed a cytokinesis-block micronucleus
(CBMN) assay to quantify micronuclei appearing after a single
complete nuclear division. Ubtf1/2 knockdown cells displayed
a significant increase in binucleated cells
exhibiting micronuclei formation (Fig. 6B,
D). To examine whether the micronucleus
phenotype observed following Ubtf1/2 de-
pletion was simply caused by reductions in
rDNA transcription and its subsequent con-
sequences on nucleolar structure or func-
tion, independent of possible effects on Pol II
transcription, we performed the CBMNassay
following RNAi depletion of the Pol I-specific
transcription factor Rrn3 (Fig. 6C,D). RRN3
has no known functions outside nucleolar
rDNA transcription. Knocking downUbtf1/2,
Ubtf1, or Rrn3 has similar consequences in
reducing 45S rRNA levels (Figs. 5A, 6C).
However, while knockdown of Ubtf1/2 led to
a significant increase in micronuclei, Rrn3
knockdown, and thus selective inhibition
of rDNA transcription, failed to increase
micronuclei numbers. Moreover, Ubtf1
knockdown only modestly increased the
percentage of cells exhibiting micronuclei,
consistent with the proposed model that
UBTF2 plays a prominent role in regulating
histone genes and other Pol II-transcribed
genes. These data reveal that the genomic
instability following Ubtf1/2 knockdown is
independent of its effects on rDNA tran-
scription per se and is likely to be a direct
consequence of reductions in Pol II gene
expression, in particular, histone genes.
Further, immunofluorescence for UBTF1/2
combined with rDNA FISH analysis demon-
strated that the micronuclei associated with
Ubtf1/2 knockdown did not overlap with the
rDNA signal, indicating that genomic mate-
rial in these micronuclei are not solely de-
rived from rDNA-bearing chromosomes
(Supplemental Fig. 6) and do not merely
reflect genomic instability of the rDNA repeats but rather ge-
nome-wide chromosome instability.
Discussion
UBTF1/2 couples the regulation of a subset of highly
transcribed Pol I and Pol II genes
In this study we demonstrate a fundamental role for the Pol I tran-
scription factorUBTF1/2 in regulatinghighly transcribed Pol II genes,
including the histone gene clusters. Moreover, in transformed cells,
we demonstrate that UBTF1/2 is enriched at an additional cohort of
genes involved in DNA damage and repair, including mediators of
ATR/ATM-regulated DNA damage response, signal transduction by
TP53, andG1 to S transition of the cell cycle. Activation of the ATM/
ATR-regulated DNA damage network following oncogenic stress is
proposed tobe abiological response todelay or protect against cancer
(Bartkova et al. 2005) by pausing cells in S phase or G2 to allow ap-
propriate repair of damagedDNA. It is tempting to speculate that this
additional cohort of UBTF1/2 target genes represents a regulated re-
sponse to oncogenic stress to couple the rate of rDNA transcription
with DNA integrity and fidelity of chromatin assembly.
Thus collectively, the data indicate that UBTF1/2 binding is
dynamic, context dependent, and potentially associated with
Figure 5. The UBTF2 isoform mediates histone gene expression. (A) Total protein lysates from
NIH3T3 cells transfected with sirEgfp, sirUbtf1/2#1, sirUbtf1/2#2, or sirUbtf1 for 48 h were analyzed
by Western blotting (top panel). RNA was also extracted and 45S rRNA precursor levels were de-
termined by reverse transcription qPCR using primers to the 59 external transcribed region (ETS)
(Supplemental Table 20). 45S rRNA levels were normalized to Gapdh mRNA and expressed as fold
change relative to sirEgfp control (n = 3; Ave 6 SEM). (*) P-value < 0.05 (bottom panel). (B) (Top
panel) qChIP analysis of UBTF1/2 binding to histone H2a, H1, and H4 genes in NIH3T3 cells
transfectedwith either sirEgfp, sirUbtf1/2#1, or sirUbtf1 for 48 h (n = 3; Ave6 SEM). (*) P-value < 0.05
compared to sirEgfp sample. qChIPs were performed as described in Figure 4C. (Bottom panel) G1
populations of NIH3T3 cells transfected as above were sorted as described in Figure 4A, and total
RNA was extracted. Histone H2a, H1, and H4mRNA levels were determined by reverse transcription
qPCR. mRNA levels were normalized to B2m mRNA and expressed as fold change relative to the




malignant transformation. While a number of Pol II transcription
factors have been implicated in the regulation of Pol I, for example,
MYC, TP53, and RUNX2 (Hannan et al. 2013), our data provide the
first specific in vivo example of a Pol I factor with dual functions in
the regulation of Pol I and Pol II.
Interestingly, although ribosomal protein (RP) encoding
genes, like histone genes, are also highly expressed genes (Castillo-
Davis et al. 2002), they did not appear in the gene ontological
analysis of genes bound by UBTF1/2 in NIH3T3 (Supplemental
Fig. 2A) nor did they change in mRNA levels upon Ubtf1/2
knockdown (Supplemental Table 15). In fact, UBTF1/2 ChIP-seq
peaks in NIH3T3 cells were detected at only five RP genes. Thus,
the data do not support a model in which ribosome biogenesis is
coordinated at the transcriptional level by UBTF1/2. Instead, it is
consistent with the prevailing view that in mammals, the major
mode of coordinated regulation of ribosome biogenesis is achieved
post-transcriptionally via specific conserved signaling networks
including the PI3K/AKT/TOR and ERK pathways (White 2008;
Chan et al. 2011; Hannan et al. 2011, 2013; Bywater et al. 2013;
Chauvin et al. 2014). This appears in contrast to lower organisms
such as yeast where transcription of the rRNAs by Pol I and the RPs
by Pol II is coordinated (Laferte et al. 2006; Berger et al. 2007). We
note that in higher eukaryotes, RPs have evolved extra-ribosomal
functions, for example, in regulating nucleolar stress and TP53
Figure 6. Ubtf1/2 knockdown leads to DNA damage and genomic instability. (A) NIH3T3 cells were transfected with sirEgfp or sirUbtf1/2#1 for 48 h and
DNA damagewasmeasured by comet assay. Representative images of SYBR green-stainedDNA of sirEgfp control cells, showing undamaged and supercoiled
DNA remaining within the nuclear membrane, while in sirUbtf1/2#1 cells, denatured DNA fragments migrate out from the nucleus in a comet tail. The tail
length for;50 nuclei for each sample from two independent experiments wasmeasured usingmetamorph software. The graph on the right panel represents
Ave6 SEM. (*) P-value < 0.05 compared to sirEgfp control. (B) Ubtf1/2 knockdown leads to abnormal mitosis as measured by the CBMN assay. NIH3T3 cells
transfectedwith sirEgfpor sirUbtf1/2#1were incubated for 24 h, thenCytochalasin B, an inhibitor of cytokinesis, was added at 3 mg/mL for a further 24 h.DAPI
staining was then performed and percentages of binucleated cells exhibiting micronuclei were scored (yellow arrows) (n = 3; Ave6 SEM). (*) P < 0.05. (C )
Forty-eight hours after transfecting NIH3T3 cells with sirEgfp, sirUbtf1/2#1, or sirRrn3, total RNA was extracted, and Ubtf1/2 mRNA, Rrn3 mRNA, and 45S
rRNA precursor levels were determined by reverse transcription qPCR. mRNA levels were normalized to B2mmRNA and expressed as fold change relative to
the sirEgfp control (n = 3; Ave6 SEM). (*) P-value < 0.05, (**) P-value < 0.01, (***) P-value < 0.001, compared to corresponding sirEgfp controls. (D) NIH3T3
cells were transfected with siRNA oligos as indicated, and the CBMN assay was performed as described in B (n = 3). Approximately 100 cells were counted in
each experiment and percentages of binucleated cells exhibiting micronuclei were scored (Ave 6 SEM). (*) P-value < 0.05 compared to sirEgfp control.
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accumulation through the binding of certain RPs to MDM2
(Boulon et al. 2010; Deisenroth and Zhang 2010; Hein et al. 2013).
The transcriptional uncoupling of rRNA andRP synthesis in higher
eukaryotes may allow for regulation of the extra-ribosomal func-
tions of RPs by mechanisms and signaling pathways independent
of those that modulate ribosome biogenesis.
Ubtf1/2 are splice variants from a single transcript and their
expression is dynamically regulated by >90% during terminal dif-
ferentiation and proliferation, which coincides with dramatic
changes in the rDNA transcription rate (Larson et al. 1993; Moss
and Stefanovsky 2002; Sanij et al. 2008; Sanij and Hannan 2009;
Poortinga et al. 2011, 2014; Bywater et al. 2012). Conversely, they
are robustly up-regulated under proliferative conditions (Moss and
Stefanovsky 2002; Sanij and Hannan 2009; Bywater et al. 2012;
Poortinga et al. 2014). Critically, our previous studies demon-
strated that UBTF2 does not function in Pol I transcription, raising
the perplexing question about the UBTF2 function in vivo (Sanij
et al. 2008). In this study we demonstrated that UBTF2 is sufficient
in the absence of UBTF1 to modulate Pol II gene expression.
Moreover, depletion of Ubtf1 alone had little effect on Pol II-
dependent transcription of the histone genes but robustly repressed
Pol I-dependent transcription of the rDNA (Fig. 5). Together, these
data suggest that UBTF1 functions predominantly in regulating Pol I,
while UBTF2 functions in regulating Pol II. Alternative splicing for
the same gene to yield two distinct mRNA isoforms, with specific
roles in regulating Pol I (Ubtf1) and Pol II (Ubtf2) transcription, re-
spectively, appears to be an ideal evolutionarymechanism to couple
the regulation of highly transcribed genes required for fundamental
processes such as rRNA synthesis and chromatin assembly.
Recruitment of UBTF1/2 to open chromatin
The interphase genome is organized into self-interacting topo-
logical domains flanked by boundaries. These regions are remod-
eled by Pol II and topoisomerase activities creating supercoiling
domains. Underwound, negatively supercoiled domains are tran-
scriptionally active, enriched in ‘‘open’’ chromatin fibers, DNase I
hypersensitive sites, and TSSs (Naughton et al. 2013) reminiscent
of chromatin structures bound by UBTF1/2 (Figs. 1C,F, 2A). Like
other HMG proteins, UBTF1/2 has little intrinsic DNA binding
specificity in vitro. One possibility is that UBTF1/2 may recognize
specific topological features that are characteristic of specific DNA
regions with very high constitutive transcriptional activity. In-
deed, intersection of UBTF1/2-bound regions with DNA super-
coiling data across seven genomic loci that distinguish between
negative supercoiled ‘‘underwound’’ and positively supercoiled
‘‘overwound’’ DNA (Naughton et al. 2013) demonstrates that
;83% of the overlapping regions represent underwound DNA
(data not shown). Thus, UBTF1/2may ‘‘mark’’ and stabilize regions
of constitutively active ‘‘underwound’’ DNA structures. In turn,
this may facilitate rapid induction of mRNA synthesis during the
cell cycle or in response to extracellular stimuli.
UBTF1/2 as a mediator of genomic stability
UBTF1/2 deficiency, but not reductions in Pol I transcription per se,
resulted in genome-wide instability in NIH3T3 cells (Fig. 6). Almost
certainly the role UBTF1/2 plays in maintaining high levels of ca-
nonical and noncanonical histones and other genes involved in
chromatin assembly and DNA damage response contributes to the
genomic instability upon Ubtf1/2 knockdown. This would be consis-
tent with the observations that histone insufficiency during S phase
results in spontaneous DNA damage and genomic instability (Han
et al. 1987;Myung et al. 2003; Ye et al. 2003; Prado andAguilera 2005;
Clemente-Ruiz and Prado 2009) and that manipulation of core his-
tone function or abundance causes defects in chromosome segrega-
tion (Meeks-Wagner and Hartwell 1986; Pinto and Winston 2000).
Thus, through its ability to coordinately regulate the expression
of some of the most highly transcribed Pol I and Pol II genes in the
genome including the histones clusters and rDNA repeats, our data
demonstrate a previously unrecognized but fundamental role for the
two isoforms of UBTF1/2 in coupling Pol I transcription and the cell’s
capacity to grow with the fidelity of chromatin assembly and DNA
repair. Intriguingly, it has recently been demonstrated that inhibition
of Pol I is an effectivemechanism to treat hematological cancers with
drugs targeting Pol I transcription now in clinical trials (Bywater et al.
2012, 2013). We propose that the unique characteristics of UBTF1/2
to target a subset of Pol II genes critical for cell proliferation, in ad-
dition to Pol I, make it a highly attractive target for cancer therapy.
Methods
ChIP and ChIP-seq analysis
Standard ChIP was carried out as described (Poortinga et al. 2004;
Sanij et al. 2008). Antibodies and primer sequences are listed in the
Supplemental Data. ChIP-reChIP experiments were carried out as
described in Mendoza-Parra (2012). Anti-UBTF1/2 sera were cross-
linked to protein A beads using disuccinimidyl suberate. UBTF1/2
ChIP products were eluted in 1%SDS, 0.1 MNaHCO3, diluted 1:10
and subjected to a second ChIP using antibodies directed against
Pol I, Pol II, or RS.
For ChIP-seq of UBTF1/2 ChIP DNA and input gDNA from
NIH3T3, libraries from two biological replicates were prepared for
the Illumina Genome Analyzer II platform at Peter MacCallum
Cancer Center. ChIP-seq libraries of histonemodifications and Pol
II in NIH3T3 libraries were also prepared for the Illumina Genome
Analyzer II platform. Sequencing reads were mapped to the mouse
genome database mm9 using the Burrows-Wheeler Aligner (BWA)
(Li and Durbin 2009). ChIP-seq of UBTF1/2 ChIP, Pol I, and gDNA
samples in HMEC was performed using the Illumina Genome
Analyzer II platform, while ChIP-seq of UBTF1/2 ChIP and gDNA
samples inHMLER cells was performed using IlluminaHiSeq 1000.
Sequences were mapped to the human genome (hg19). MACS 1.4
(Model-based Analysis of ChIP-seq [Zhang et al. 2008]) was used to
call peaks over input DNA, and the fold enrichment for each peak
was calculated using the R package (Gentleman et al. 2004). Only
peak regions with a false discovery rate (FDR) <10% and P-value <
0.00001 were selected and annotated with RefSeq annotation us-
ing the R package ChIPpeakAnno (Zhu et al. 2009). The distribu-
tion of UBTF1/2 peaks relative to RefSeq genes as well as the
comparison of ChIP-seq data sets was performed using the Sole-
Search software tool (Blahnik et al. 2010). The DNase I hypersen-
sitivity profile in NIH3T3 cells was obtained from the ENCODE
UCSC Genome Browser (https://www.encodeproject.org/, Acces-
sion: ENCSR000CNS).
Gene expression analysis
We performed microarray analysis (Affymetrix, Mouse Exon ST
1.0 arrays) on three biological replicates of Ubtf1/2 knockdown
samples using two independent siRNA oligos, a nonsilencing
sirEgfp or mock-transfected NIH3T3 samples (Supplemental Table
18). The arrays were normalized using the robust multiarray av-
erage expression measure (RMA) (Irizarry et al. 2003), and dif-
ferential expression was then determined using a linear model
and the Limma package (http://bioinf.wehi.edu.au/limma/)




cance was assessed using the log-fold change and FDR-adjusted
P-value.
Correlation analysis of UBTF1/2 ChIP-seq and microarray
expression data
Expression data of exponentially growing NIH3T3 were obtained
using Affymetrix, Mouse Exon ST 1.0 arrays (mock samples from
previous section). Triplicates were normalized using the RMA
method (Irizarry et al. 2003) and expression values for all genes,
genes with significant UBTF1/2 peaks < 2 kb from their TSS, or
genes with no UBTF1/2 binding at their TSS, were obtained.
Statistical significance between the groups was assessed using
t-tests.
Cell culture, siRNA knockdown, and RNA expression analysis
NIH3T3 cells were cultured inDulbecco’smodified Eagle’smedium
(DMEM) with 10% fetal bovine serum (FBS) at 37°C. HMECs and
HMLER cells were cultured in HuMEC ready medium (12752010,
Life Technologies). Dharmafect 2 reagent (Dharmacon) was used
to transfect siRNA at 40 nM. The tetracycline-regulated rat Ubtf1
and Ubtf2 MEF-3T3 cell lines were established as reported in Sanij
et al. (2008). Cells were lysed, RNA was extracted, and first-strand
cDNA was synthesized using random hexamer primers and
Superscript III (Invitrogen). Quantitative PCR (qPCR) was performed
in duplicate using the FAST SYBRGreen dye on the StepOnePlus real-
time PCR system (Applied Biosystems). Primer sequences are listed in
(Supplemental Table 20).
Western blotting and immunofluorescence
Twenty to fiftymilligrams of whole-cell lysates were resolved by SDS-
PAGE, electrophoretically transferred onto PVDF membranes (Milli-
pore), and analyzed using enhanced chemiluminescence (ECL)
detection (GE Healthcare). For IF, cells were fixed in 4% para-
formaldehyde (10 min at room temperature), washed with PBS, and
blocked with 5% skimmilk powder, 0.5% chicken serum in PBS, and
0.3%TritonX-100 for 30min. Cells were sequentially incubatedwith
anti-UBTF1/2 sera and Alexa Fluor 594 anti-rabbit secondary anti-
body (Molecular Probes). Stained cells were fixed again with 4%
formaldehyde and counterstained with DAPI in Vectashield mount-
ingmedia (Vector Labs). Images were acquired on anOlympus BX-51
microscope equipped with a Spot RT camera (model 25.4), using the
UPlanAPO 403, NA 1.2 water immersion objective and the Spot
Advanced software, version 4.6.4.3. Settings for adjusting the
image after acquisition (i.e., gamma adjust and background
subtract settings) were identical for all images. A detailed FISH
protocol is provided in the Supplemental Methods.
COMET assay
Cellswere collected andprocessed asdescribed in themanufacturer’s
protocol (Trevigen, Comet Assay 4250-050-K). Images were acquired
on an Olympus BX-51 microscope using the Olympus UPlanAPO
203, NA 1.2 water immersion objective as described above. Quan-
titation was performed using MetaMorph (Molecular Devices).
CHART-PCR assay
Cells were collected and mononucleosome preparations were
performed using an EpiScope nucleosome preparation kit (#5333;
Takara). Briefly, nuclei were isolated from control and Ubtf1/2
depleted cells and incubated at 37°C for 30 min with MNase. A
control without MNase was included for each sample. gDNA was
then isolated and subjected to qPCR using FAST SYBR Green dye
on the StepOnePlus real-time PCR system (Applied Biosystems).
The relative level of MNase resistance was calculated after nor-
malization to mock-digested DNA.
Data access
Raw ChIP-seq data is available through the NCBI Sequence Read
Archive (SRA, http://www.ncbi.nlm.nih.gov/sra/) under accession
number SRP039369. Processed ChIP-seq data and microarray ex-
pression data have been submitted to the NCBI Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) under acces-
sion numbers GSE63255 and GSE55461, respectively.
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